F 0644
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Coordinate assessments with the pre-admission screening and resident review program; and referring for
services as needed.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
observation, medical record review, review of the pre-admission screening and resident review (PASARR)
assessment, and staff interview, the facility failed to implement specialized services as indicated in the
PASARR level II outcome determination letter. This affected one (#50) of three residents reviewed for
PASARR. The facility census was 82.
Findings include:
Medical record review revealed Resident #50 was admitted on [DATE] with diagnoses including
schizoaffective bipolar type disorder, delusional disorder, panic disorder, auditory hallucinations, psychosis,
suicidal ideations, depression, generalized anxiety, and insomnia.
Review of the care plan: PASARR recommendations due to significant change dated 01/11/24 revealed
interventions for interdisciplinary team to review the PASARR recommendations and follow
recommendations as able or applicable. There was no evidence the other recommended services were
added to the care plan after the PASARR determination letter was received approving Specialized Services
on 02/03/25.
Review of the significant change Minimum Data Set (MDS) 3.0 assessment dated [DATE] revealed
Resident #50's PASARR level II conditions indicated there resident had a serious mental illness and had
been discharged to an inpatient psychiatric facility.
Review of the PASARR level II outcome report dated 02/03/25 revealed it was determined Resident #50
was appropriate for nursing facility services with approved Specialized Services. The following behavioral
health services were required to be provided by the nursing facility including: a crisis intervention plan, a
behavior management safety plan to decrease inappropriate behaviors and ensure safety, ongoing
evaluation of the effectiveness of current psychotropic medication on target symptoms, ongoing medication
review by a psychiatrist or similarly credentialed professional, mental health counseling, and a behaviorally
based treatment plan. The reason for those services was to reduce mental health symptoms and provide
supports. Other recommended services the resident would need to be provided by the certified nursing
facility included but were not limited to : self-health care management training, activities of daily living (ADL)
training, therapy evaluations, skills training, adaptive equipment evaluation, and structured therapeutic
activities. The reason for the above supports was to promote health, wellness and independence.
There was no evidence in Resident #50's medical record of a crisis intervention plan or behavior
management safety plan as required or other recommendations as indicated in the PASARR determination
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 4
Event ID:
366254
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
366254
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
05/29/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Oak Pointe Nursing & Rehabilitation
130 Buena Vista Street
Baltic, OH 43804
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0644
letter dated 02/03/25.
Level of Harm - Minimal harm
or potential for actual harm
On 05/27/25 at 12:17 P.M., observation and interview revealed Resident #50 was laying in bed and refused
to acknowledge Registered Nurse (RN) #215 or speak to the surveyor. RN #215 stated Resident #50 has
not been receptive to staff and stated Resident #50 might need her medications adjusted. RN #215 stated
Resident #50 was seen by the psychiatrist but did not know if the resident had a crisis plan.
Residents Affected - Few
On 05/28/25 at 3:03 P.M., interview with Clinical Coordinator/Licensed Practical Nurse #271 verified there
was no evidence the required PASARR services had been implemented after Resident #50 was approved
for Specialized Services on 02/03/25.
On 05/29/25 at 8:07 A.M., interview with Social Service Designee (SSD) #273 verified Resident #50's
PASARR was approved with specialized services and these had not been addressed to date.
On 05/29/25 at 9:40 A.M., interview with SSD #273 stated when he receives the PASARR Level II
outcomes, he reviews the determination and then he was to update the care plan. SSD #273 notifies the
clinical coordinator and physician to see if they want to order any of those services on the determination
letter. SSD #273 stated he did not realize the behavioral health services and Specialized Services were
required to be provided per the determination letter by the admitting nursing facility.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
366254
If continuation sheet
Page 2 of 4
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
366254
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
05/29/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Oak Pointe Nursing & Rehabilitation
130 Buena Vista Street
Baltic, OH 43804
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0759
Ensure medication error rates are not 5 percent or greater.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
observation, medical record review, policy review, review of manufacturer guidelines and Medscape
guidance, and staff interview, the facility failed to ensure their medication error rate did not exceed five
percent (%). Nine errors occurred within 26 opportunities for an error rate of 34.6%. This affected three
(#17, #62, and #72) of five residents observed for medication administration. The facility census was 82.
Residents Affected - Few
Findings include:
1. Medical record review revealed Resident #17 was admitted on [DATE] with diagnoses including
schizophrenia, paraplegia, congestive heart failure, and anxiety disorder.
Review of Resident #17's physician orders dated May 2025 revealed to administer medications upon rising
which included Aripiprazole (antipsychotic) 7.5 milligrams (mg).
Review of the pharmacy pre-packaged pouch labeled At Rise for Resident #17 dated 05/27/25 revealed the
pouch included Aripiprazole 7.5 mg with instructions 'Do Not Crush'.
On 05/27/25 between 9:26 A.M. and 9:35 A.M., observation revealed Licensed Practical Nurse (LPN) #255
prepared Resident #17's medications including Aripiprazole and eight other medications. LPN #22 placed
the nine medications into a plastic sleeve including the Aripiprazole and crushed the medications. LPN
#255 put the crushed tablets in pudding and administered the medications to Resident #17.
On 05/27/25 at 9:57 A.M., interview with LPN #255 verified she crushed Resident #17's Aripiprazole and
the pharmacy instructions on the pre-packaged pouch indicated do not crush Aripiprazole.
Review of Medscape guidance found at
https://reference.medscape.com/drug/Abilify-maintena-aristada-aripiprazole-342983#11 revealed to
swallow tablet whole; do not divide, crush, or chew.
2. Medical record review revealed Resident #72 was admitted on [DATE] with diagnoses including anxiety,
Alzheimer's disease, hypertension and psychosis.
Review of the physician orders dated May 2025 revealed to administer medications including tramadol
(opioid), ativan (anxiety), benazepril (blood pressure), Colace (stool softener), famotidine
(gastroesophageal reflex disease), Meloxicam (nonsteroidal anti-inflammatory), Miralax (stool softener),
and lactulose liquid (stool softener).
On 05/27/25 between 9:38 A.M. and 9:55 A.M., observation revealed Licensed Practical Nurse (LPN) #255
prepared Resident #72's At Rise medications including tramadol, ativan, benazepril, colace, famotidine and
Meloxicam into a plastic sleeve, crushed the medications and put the crushed tablets in pudding. LPN #255
prepared Resident #72's Miralax in six ounces of water, lactulose liquid dose was poured into a glass of
nutritional supplement and the above medications were taken to the lounge area where Resident #72 was
seated in a specialty wheelchair. LPN #255 was observed scooping the crushed medications from the
medication cup with a plastic spoon into Resident #72's mouth. The resident was observed to take the
crushed medications in pudding that was heaping above the rim of the spoon; however, the bowl of the
plastic spoon remained full of crushed medications and pudding. LPN #255 poured the liquid lactulose into
the nutritional supplement and Resident #72 drank approximately five
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
366254
If continuation sheet
Page 3 of 4
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
366254
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
05/29/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Oak Pointe Nursing & Rehabilitation
130 Buena Vista Street
Baltic, OH 43804
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0759
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
ounces of the nutritional supplement. The remaining doses of the crushed medications and liquid
medications were all discarded in the trash.
On 05/27/25 at 9:57 A.M., interview with LPN #255 verified the entire dose of crushed medications and
liquid medication were not administered to Resident #72 and had been discarded in the trash. LPN #255
was unable to state which medications and how much of the medication was left in the pudding or
nutritional supplement due to the medications were mixed together.
3. Medical record review revealed Resident #62 was admitted on [DATE] with diagnoses including
congestive heart failure.
Review of the physician orders dated May 2025 revealed to administer medications including Eliquis
(anticoagulant), Lasix (diuretic), and Sacubitril-Valsartan (treats heart failure; also known as Entresto).
On 05/28/25 at 3:30 P.M., observation of Resident #62's medication administration revealed Registered
Nurse (RN) #281 placed Eliquis, Lasix and Sacubitril-Valsartan into a plastic sleeve, crushed the
medication, put the crushed tablets in chocolate pudding and administered the medications to Resident
#62.
On 05/28/25 at 3:57 P.M., interview with RN #281 verified the above observation and stated the
medications including Sacubitril-Valsartan were crushed because Resident #62 would chew the
medications if not crushed.
Review of the Novartis: Entresto manufacturer guidelines dated April 2024 does not recommend the
splitting or crushing of Entresto. If you cannot swallow tablets, or if tablets are not available in the prescribed
strength, you may take Entresto tablets prepared as a liquid (oral) suspension or may take Entresto
sprinkle.
Review of the policy titled Medication Administration dated 06/21/17 revealed medications were to be
administered by legally-authorized and trained persons in accordance to applicable state, local and federal
lows and consistent with accepted standards of practice.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
366254
If continuation sheet
Page 4 of 4